319 related articles for article (PubMed ID: 20571983)
1. Metachromatic leukodystrophy--an update.
Gieselmann V; Krägeloh-Mann I
Neuropediatrics; 2010 Feb; 41(1):1-6. PubMed ID: 20571983
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of different forms of metachromatic leukodystrophy.
Polten A; Fluharty AL; Fluharty CB; Kappler J; von Figura K; Gieselmann V
N Engl J Med; 1991 Jan; 324(1):18-22. PubMed ID: 1670590
[TBL] [Abstract][Full Text] [Related]
3. Genetics of metachromatic leukodystrophy.
Gieselmann V; Kreysing J; von Figura K
Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
[TBL] [Abstract][Full Text] [Related]
4. Metachromatic leukodystrophy: subtype genotype/phenotype correlations and identification of novel missense mutations (P148L and P191T) causing the juvenile-onset disease.
Qu Y; Shapira E; Desnick RJ
Mol Genet Metab; 1999 Jul; 67(3):206-12. PubMed ID: 10381328
[TBL] [Abstract][Full Text] [Related]
5. An unusual homozygous arylsulfatase: a pseudodeficiency in a metachromatic leukodystrophy Tunisian patient.
Tinsa F; Caillaud C; Vanier MT; Bousnina D; Boussetta K; Bousnina S
J Child Neurol; 2010 Jan; 25(1):82-6. PubMed ID: 19574581
[TBL] [Abstract][Full Text] [Related]
6. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy].
Horovenko NH; Ol'khovych NV; Pichkur NO
Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547
[TBL] [Abstract][Full Text] [Related]
7. Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype.
Rauschka H; Colsch B; Baumann N; Wevers R; Schmidbauer M; Krammer M; Turpin JC; Lefevre M; Olivier C; Tardieu S; Krivit W; Moser H; Moser A; Gieselmann V; Zalc B; Cox T; Reuner U; Tylki-Szymanska A; Aboul-Enein F; LeGuern E; Bernheimer H; Berger J
Neurology; 2006 Sep; 67(5):859-63. PubMed ID: 16966551
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of metachromatic leukodystrophy.
Gieselmann V; Zlotogora J; Harris A; Wenger DA; Morris CP
Hum Mutat; 1994; 4(4):233-42. PubMed ID: 7866401
[TBL] [Abstract][Full Text] [Related]
9. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
Gieselmann V
Acta Paediatr; 2008 Apr; 97(457):15-21. PubMed ID: 18339182
[TBL] [Abstract][Full Text] [Related]
10. Metachromatic leukodystrophy: identification of the first deletion in exon 1 and of nine novel point mutations in the arylsulfatase A gene.
Draghia R; Letourneur F; Drugan C; Manicom J; Blanchot C; Kahn A; Poenaru L; Caillaud C
Hum Mutat; 1997; 9(3):234-42. PubMed ID: 9090526
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in the arylsulfatase A gene in eight Italian families with metachromatic leukodystrophy.
Bertelli M; Gallo S; Buda A; Cecchin S; Fabbri A; Lapucci C; Andrighetto G; Sidoti V; Lorusso L; Pandolfo M
J Clin Neurosci; 2006 May; 13(4):443-8. PubMed ID: 16678723
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
Olkhovich NV; Takamura N; Pichkur NA; Gorovenko NG; Aoyagi K; Yamashita S
Mol Genet Metab; 2003 Nov; 80(3):360-3. PubMed ID: 14680985
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
14. Identification of a new Arylsulfatase A (ARSA) gene mutation in Tunisian patients with metachromatic leukodystrophy (MLD).
Dorboz I; Eymard-Pierre E; Kefi R; Abdelhak S; Miladi N; Boespflug-Tanguy O;
J Neurol Sci; 2009 Dec; 287(1-2):278-80. PubMed ID: 19699491
[TBL] [Abstract][Full Text] [Related]
15. Complex arylsulfatase A alleles causing metachromatic leukodystrophy.
Kappler J; Sommerlade HJ; von Figura K; Gieselmann V
Hum Mutat; 1994; 4(2):119-27. PubMed ID: 7981715
[TBL] [Abstract][Full Text] [Related]
16. Late juvenile metachromatic leukodystrophy (MLD) in three patients with a similar clinical course and identical mutation on one allele.
Tylki-Szymanska A; Berger J; Löschl B; Lugowska A; Molzer B
Clin Genet; 1996 Nov; 50(5):287-92. PubMed ID: 9007312
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
18. Developing treatment options for metachromatic leukodystrophy.
Batzios SP; Zafeiriou DI
Mol Genet Metab; 2012 Jan; 105(1):56-63. PubMed ID: 22078456
[TBL] [Abstract][Full Text] [Related]
19. [2 familial cases of metachromatic leukodystrophy of late onset].
Brault JL; Gielselmann V; Carpentier A; Lefèvre M; Turpin JC; Baumann N
Rev Neurol (Paris); 1997 Apr; 153(3):193-6. PubMed ID: 9296133
[TBL] [Abstract][Full Text] [Related]
20. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers.
Harrington M; Whalley D; Twiss J; Rushton R; Martin S; Huynh L; Yang H
Orphanet J Rare Dis; 2019 Apr; 14(1):89. PubMed ID: 31036045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
